NCT07042334 Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
| NCT ID | NCT07042334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Serious Games |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-01-22 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-01-22 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study involves testing a new video game designed to support adolescents with congenital heart disease (CHD) in preparing to manage their health independently. The game aims to teach essential skills such as communicating with healthcare providers, understanding medical information, and managing appointments and medications. This small pilot study will evaluate the game's usability, acceptability, and its impact on participants' confidence and preparedness for managing their heart care. Feedback will be collected from adolescent participants, their parents, and healthcare providers, and the study will examine how the game influences communication during clinical visits.
Eligibility Criteria
Inclusion criteria: \- Patient with congenital heart disease, their parent, and their clinician Exclusion criteria: -Significant visual or cognitive impairment that would impede their ability to play the game and/or complete the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07042334 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Serious Games. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07042334 currently recruiting?
Yes, NCT07042334 is actively recruiting participants. Contact the research team at rebecca.delaney@hsc.utah.edu for enrollment information.
Where is the NCT07042334 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT07042334 clinical trial?
NCT07042334 is sponsored by University of Utah. The trial plans to enroll 150 participants.